THE PENNANT GROUP, INC. Operating Lease, Expense
THE PENNANT GROUP, INC. (PNTG) reported Operating Lease, Expense of $13.43 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-08-05
- THE PENNANT GROUP, INC. operating lease, expense for the quarter ending 2026-06-30 was $13.43M, a 12.60% increase year-over-year.
- THE PENNANT GROUP, INC. operating lease, expense for the quarter ending 2026-03-31 was $13.10M, a 11.81% increase year-over-year.
- THE PENNANT GROUP, INC. operating lease, expense for the quarter ending 2025-12-31 was $13.00M, a 15.89% increase year-over-year.
- THE PENNANT GROUP, INC. operating lease, expense for the quarter ending 2025-09-30 was $12.06M, a 10.61% increase year-over-year.
- THE PENNANT GROUP, INC. operating lease, expense for fiscal 2025 was $48.70M, a 13.18% increase from fiscal 2024.
- THE PENNANT GROUP, INC. operating lease, expense for fiscal 2024 was $43.03M, a 8.22% increase from fiscal 2023.
- THE PENNANT GROUP, INC. operating lease, expense for fiscal 2023 was $39.76M, a 4.58% increase from fiscal 2022.
- THE PENNANT GROUP, INC. operating lease, expense for fiscal 2022 was $38.02M, a 6.96% decline from fiscal 2021.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $13.43M 10-Q · filed 2026-08-05 | $26.53M 10-Q · filed 2026-08-05 | $39.52M derived: sum of 3 quarters · filed 2026-08-05 | $51.59M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $13.10M 10-Q · filed 2026-05-06 | $26.09M derived: sum of 2 quarters · filed 2026-05-06 | $38.16M derived: sum of 3 quarters · filed 2026-05-06 | $50.08M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $13.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $25.06M derived: sum of 2 quarters · filed 2026-02-26 | $36.98M derived: sum of 3 quarters · filed 2026-08-05 | $48.70M 10-K · filed 2026-02-26 |
| 2025-09-30 | $12.06M 10-Q · filed 2025-11-05 | $23.99M derived: sum of 2 quarters · filed 2026-08-05 | $35.70M 10-Q · filed 2025-11-05 | $46.92M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $11.93M 10-Q · filed 2026-08-05 | $23.64M 10-Q · filed 2026-08-05 | $34.85M derived: sum of 3 quarters · filed 2026-08-05 | $45.76M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $11.71M 10-Q · filed 2026-05-06 | $22.93M derived: sum of 2 quarters · filed 2026-05-06 | $33.84M derived: sum of 3 quarters · filed 2026-05-06 | $44.36M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $11.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $22.12M derived: sum of 2 quarters · filed 2026-02-26 | $32.65M derived: sum of 3 quarters · filed 2026-02-26 | $43.03M 10-K · filed 2026-02-26 |
| 2024-09-30 | $10.91M 10-Q · filed 2025-11-05 | $21.43M derived: sum of 2 quarters · filed 2025-11-05 | $31.81M 10-Q · filed 2025-11-05 | $42.13M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $10.52M 10-Q · filed 2025-08-06 | $20.91M 10-Q · filed 2025-08-06 | $31.23M derived: sum of 3 quarters · filed 2026-02-26 | $41.23M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $10.38M 10-Q · filed 2025-05-06 | $20.70M derived: sum of 2 quarters · filed 2026-02-26 | $30.71M derived: sum of 3 quarters · filed 2026-02-26 | $40.55M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $10.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $20.33M derived: sum of 2 quarters · filed 2026-02-26 | $30.16M derived: sum of 3 quarters · filed 2026-02-26 | $39.76M 10-K · filed 2026-02-26 |
| 2023-09-30 | $10.01M 10-Q · filed 2024-11-06 | $19.84M derived: sum of 2 quarters · filed 2024-11-06 | $29.44M 10-Q · filed 2024-11-06 | $38.94M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $9.84M 10-Q · filed 2024-08-06 | $19.43M 10-Q · filed 2024-08-06 | $28.93M derived: sum of 3 quarters · filed 2025-02-27 | $38.32M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $9.60M 10-Q · filed 2024-05-06 | $19.09M derived: sum of 2 quarters · filed 2025-02-27 | $28.49M derived: sum of 3 quarters · filed 2025-02-27 | $37.56M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $9.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $18.89M derived: sum of 2 quarters · filed 2025-02-27 | $27.97M derived: sum of 3 quarters · filed 2025-02-27 | $38.02M 10-K · filed 2025-02-27 |
| 2022-09-30 | $9.39M 10-Q · filed 2023-11-07 | $18.47M derived: sum of 2 quarters · filed 2023-11-07 | $28.52M 10-Q · filed 2023-11-07 | $38.93M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $9.08M 10-Q · filed 2023-08-08 | $19.13M 10-Q · filed 2023-08-08 | $29.54M derived: sum of 3 quarters · filed 2024-02-28 | $39.87M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $10.05M 10-Q · filed 2023-05-04 | $20.46M derived: sum of 2 quarters · filed 2024-02-28 | $30.79M derived: sum of 3 quarters · filed 2024-02-28 | $40.95M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $10.41M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $20.74M derived: sum of 2 quarters · filed 2024-02-28 | $30.90M derived: sum of 3 quarters · filed 2024-02-28 | $40.86M 10-K · filed 2024-02-28 |
| 2021-09-30 | $10.33M 10-Q · filed 2022-11-07 | $20.49M derived: sum of 2 quarters · filed 2022-11-07 | $30.45M 10-Q · filed 2022-11-07 | $40.45M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $10.16M 10-Q · filed 2022-08-08 | $20.12M 10-Q · filed 2022-08-08 | $30.12M derived: sum of 3 quarters · filed 2023-02-23 | $39.84M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $9.96M 10-Q · filed 2022-05-09 | $19.96M derived: sum of 2 quarters · filed 2023-02-23 | $29.68M derived: sum of 3 quarters · filed 2023-02-23 | $39.45M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $19.72M derived: sum of 2 quarters · filed 2023-02-23 | $29.48M derived: sum of 3 quarters · filed 2023-02-23 | $39.19M 10-K · filed 2023-02-23 |
| 2020-09-30 | $9.72M 10-Q · filed 2021-11-08 | $19.49M derived: sum of 2 quarters · filed 2021-11-08 | $29.19M 10-Q · filed 2021-11-08 | $38.80M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $9.77M 10-Q · filed 2021-08-09 | $19.47M 10-Q · filed 2021-08-09 | $29.08M derived: sum of 3 quarters · filed 2022-02-28 | $37.62M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $9.71M 10-Q · filed 2021-05-06 | $19.31M derived: sum of 2 quarters · filed 2022-02-28 | $27.85M derived: sum of 3 quarters · filed 2022-02-28 | $36.38M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $9.61M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $18.14M derived: sum of 2 quarters · filed 2022-02-28 | $26.68M derived: sum of 3 quarters · filed 2022-02-28 | $34.98M 10-K · filed 2022-02-28 |
| 2019-09-30 | $8.54M 10-Q · filed 2020-11-10 | $17.07M derived: sum of 2 quarters · filed 2020-11-10 | $25.37M 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $8.53M 10-Q · filed 2020-08-11 | $16.83M 10-Q · filed 2020-08-11 | ||
| 2019-03-31 | $8.30M 10-Q · filed 2020-05-13 | |||
| 2018-12-31 | $31.20M 10-K · filed 2021-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |